Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.86/Share

November 14, 2016 4:57 PM EST

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.86), versus ($0.95) reported last year. Revenue for the quarter came in at $715 thousand, versus $205 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment